GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Divis Laboratories Ltd
Divis Laboratories Ltd Board Meeting Scheduled for Financial Results and Dividend
BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 14 May 2026, 12:10 PM IST  ·  BSE ID: c789a252-6532-4bfb-938c-630370741ef5
View Original BSE Filing (PDF)
💡
In Simple Terms
Divis Laboratories' board will meet on May 23, 2026, to approve financial results and consider a dividend.
🤖 AI Summary
  • Divis Laboratories Ltd Board of Directors meeting scheduled for Saturday, May 23, 2026.
  • Meeting agenda includes considering audited standalone and consolidated financial results for Q4 FY26 and FY26.
  • Board will also consider recommending a dividend on equity shares for the financial year 2025-26.
  • Trading Window for company securities remains closed from April 01, 2026, until May 25, 2026.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this intimation.
👤
Who Is Affected
All shareholders are affected by the upcoming financial results and any potential dividend declared for the financial year 2025-26.
🔍
Management Signal
Management is adhering to regulatory requirements by intimating the board meeting for financial result approval and dividend consideration.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board Meeting outcome filing — check for approved financial results on May 23, 2026.
Dividend announcement — verify per share amount and record date for FY26.
Post-results analyst call details — listen for management commentary on performance.
LOW RISK The filing is a routine intimation of a board meeting, presenting no immediate risks.
💡 Investor Takeaway
Divis Laboratories Ltd has scheduled a Board Meeting on May 23, 2026, to approve its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a dividend recommendation for FY 2025-26.
⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.